Oral sodium phenylbutyrate in patients with recurrent malignant gliomas: A dose escalation and pharmacologic study

MLA

Joy D. Fisher, et al. “Oral Sodium Phenylbutyrate in Patients with Recurrent Malignant Gliomas: A Dose Escalation and Pharmacologic Study.” Neuro-Oncology, vol. 7, Apr. 2005, pp. 177–82. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bdfa1cc836f2110b8915bf24dcda1eea&authtype=sso&custid=ns315887.

APA

Joy D. Fisher, Surasak Phuphanich, Sharyn D. Baker, Kathryn A. Carson, Stuart A. Grossman, Michael A. Carducci, & Mark R. Gilbert. (2005). Oral sodium phenylbutyrate in patients with recurrent malignant gliomas: A dose escalation and pharmacologic study. Neuro-Oncology, 7, 177–182.

Chicago

Joy D. Fisher, Surasak Phuphanich, Sharyn D. Baker, Kathryn A. Carson, Stuart A. Grossman, Michael A. Carducci, and Mark R. Gilbert. 2005. “Oral Sodium Phenylbutyrate in Patients with Recurrent Malignant Gliomas: A Dose Escalation and Pharmacologic Study.” Neuro-Oncology 7 (April): 177–82. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bdfa1cc836f2110b8915bf24dcda1eea&authtype=sso&custid=ns315887.